or Try an Advanced Search...

    ETF Components for MNTL - Tema Neuroscience and Mental Health ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    VRTX D -0.35 8.52
    LLY F -0.90 4.89
    REGN F 0.36 4.53
    ALNY D -0.68 4.52
    ARGX A 0.75 4.48
    NBIX C 1.39 4.14
    CRNX B 1.50 3.88
    TEVA C 0.32 3.72
    BIIB F 1.54 3.57
    SYK A 1.04 3.08
    MDT D 0.57 2.90
    IONS F -4.38 2.66
    ITCI B -0.18 2.54
    DNLI D -0.86 2.26
    XENE D 1.86 2.25
    CPRX C -0.24 2.22
    RNA C -1.67 2.14
    DAWN D -1.76 2.10
    AXSM B 4.63 1.96
    SRPT F -0.88 1.88
    JAZZ B 4.75 1.81
    DXCM C -0.57 1.80
    ACAD C -0.61 1.61
    NTLA F 5.11 1.56
    ALKS C -0.69 1.47
    IMVT F 1.51 1.46
    PEN B 0.29 1.24
    PTCT B 3.12 1.18
    DYN D -0.27 1.17
    SRRK B -3.98 1.09
    PRTA F 0.87 1.03
    OPCH F 2.24 0.96
    ACHC F -1.76 0.88
    VYGR F 1.49 0.87
    ALEC F 3.44 0.67
    QTRX F 5.17 0.57
    ARVN F 9.74 0.46

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Medicine Biotechnology Cancer Pain Alzheimer's Disease S&P 500 Biology Cholesterol Disease Life Sciences Parkinson's Disease Schizophrenia Amyloid Clinical Development Diabetes Disorders Genetics Neurological Disorders Chronic Pain
    Industries: Biotechnology Medical Devices Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Care Diagnostics & Research

    Recent News for Tema Neuroscience and Mental Health ETF & its Holdings

    Date Stock Title
    Nov 21 LLY Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
    Nov 21 MDT Here's Why Medtronic (MDT) is a Strong Value Stock
    Nov 21 DXCM 3 US Stocks Estimated To Be Trading At Discounts Of Up To 39.3%
    Nov 21 ALKS Are Options Traders Betting on a Big Move in Alkermes (ALKS) Stock?
    Nov 21 JAZZ Zymeworks, Jazz Pharmaceuticals Receive FDA's Accelerated Approval for Ziihera to Treat Biliary Tract Cancer
    Nov 21 MDT 3 Dividend Stocks I'll Never Sell
    Nov 21 JAZZ Jazz and Zymeworks announce FDA approval of cancer therapy Ziihera
    Nov 21 MDT Medtronic’s insulin pen app gains FDA clearance
    Nov 21 LLY Eli Lilly, Verge announce milestones in ALS collaboration
    Nov 21 TEVA Teva Pharmaceutical (TEVA): The Global Leader in Affordable Medicine Under $25
    Nov 21 LLY Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
    Nov 21 JAZZ Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)
    Nov 20 LLY Jim Cramer on Eli Lilly and Company (LLY): ‘I’m Kind Of Blown Away’
    Nov 20 DAWN Day One Announces Retirement of Dr. Samuel Blackman, Co-Founder and Head of Research & Development
    Nov 20 PEN Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference
    Nov 20 MDT Medtronic plc (MDT): A Key Player in Ken Griffin’s Portfolio with Steady Growth
    Nov 20 LLY Eli Lilly in pact with Chinese biotech for novel weight loss therapy
    Nov 20 BIIB Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
    Nov 20 LLY More companies covering weight loss drugs for their employees
    Nov 20 LLY Weight loss drug makers want more insurance plans to cover Wegovy and Zepbound
    Under normal circumstances, the Tema Neuroscience and Mental Health ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in neuroscience and mental health companies. A company is generally considered to be a neuroscience or mental health company that derives at least 50% of revenues from neuroscience or neurology-related diseases, or mental health. The fund is non-diversified.
    Neuroscience Neurophysiology Neurology Nervous System
    Back to the Main MNTL Page...